Cholic acid

Cholic acid is a lipid of Sterol Lipids (ST) class. Cholic acid is associated with abnormalities such as Cholestasis, Intrahepatic Cholestasis, Atherosclerosis, Diabetes and cholesterol gallstones. The involved functions are known as Homeostasis, Enterohepatic Circulation, Proliferation (morphologic abnormality), Process and Cell Proliferation. Cholic acid often locates in Hepatic, Cytoplasmic matrix, Membrane, Protoplasm and Tissue membrane. The associated genes with Cholic acid are CYP27A1 gene, ABCB11 gene, NR5A2 gene, SLC10A2 gene and SLC10A1 gene. The related lipids are ursocholic acid, Steroids, Cholestenes, Cholestanes and cholanic acid.

Cross Reference

Introduction

To understand associated biological information of Cholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Cholic acid?

Cholic acid is suspected in Cholestasis, Obesity, Intrahepatic Cholestasis, Diabetes, cholesterol gallstones, Liver diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Cholic acid

MeSH term MeSH ID Detail
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Arteriosclerosis D001161 86 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Atherosclerosis D050197 85 associated lipids
Insulin Resistance D007333 99 associated lipids
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Total 10

PubChem Associated disorders and diseases

What pathways are associated with Cholic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Cholic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Cholic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Cholic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Cholic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Cholic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Cholic acid

Download all related citations
Per page 10 20 50 100 | Total 3696
Authors Title Published Journal PubMed Link
Wang Z et al. Caveolae Depletion Contributes to Vasorelaxant Effects of Chenodeoxycholic Acid. 2017 Cell. Physiol. Biochem. pmid:28662517
Giricz Z et al. Hypercholesterolemia downregulates autophagy in the rat heart. 2017 Lipids Health Dis pmid:28330474
Li Y and Zhu C Mechanism of hepatic targeting via oral administration of DSPE-PEG-cholic acid-modified nanoliposomes. 2017 Int J Nanomedicine pmid:28280334
Valanejad L et al. Differential Feedback Regulation of Δ4-3-Oxosteroid 5β-Reductase Expression by Bile Acids. 2017 PLoS ONE pmid:28125709
Yu Y et al. Simple Strategy for Taming Membrane-Disrupting Antibiotics. 2016 Bioconjug. Chem. pmid:27801580
Smits MM et al. Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients. 2016 Diabetes Obes Metab pmid:27451030
Sun L et al. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling. 2016 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:27151938
Li C et al. Metabolomic Characterizations of Liver Injury Caused by Acute Arsenic Toxicity in Zebrafish. 2016 PLoS ONE pmid:26967897
Djanic M et al. Docking-based preliminary study on the interactions of bile acids with drugs at the transporter level in intestinal bacteria. 2016 Eur Rev Med Pharmacol Sci pmid:26914133
Santos-López JA et al. Effects of Silicon vs. Hydroxytyrosol-Enriched Restructured Pork on Liver Oxidation Status of Aged Rats Fed High-Saturated/High-Cholesterol Diets. 2016 PLoS ONE pmid:26807847
Kong B et al. Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis. 2016 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:26744468
Zietak M and Kozak LP Bile acids induce uncoupling protein 1-dependent thermogenesis and stimulate energy expenditure at thermoneutrality in mice. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:26714852
McMillin M et al. Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure. 2016 Am. J. Pathol. pmid:26683664
Dossa AY et al. Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling. 2016 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:26608185
Heverin M et al. 27-hydroxycholesterol mediates negative effects of dietary cholesterol on cognition in mice. 2015 Behav. Brain Res. pmid:25453744
He XQ et al. Effects of Two Traditional Chinese Cooking Oils, Canola and Pork, on pH and Cholic Acid Content of Faeces and Colon Tumorigenesis in Kunming Mice. 2015 Asian Pac. J. Cancer Prev. pmid:26434820
Zhang W et al. Tandem mass spectrometric determination of atypical 3β-hydroxy-Δ5-bile acids in patients with 3β-hydroxy-Δ5-C27-steroid oxidoreductase deficiency: application to diagnosis and monitoring of bile acid therapeutic response. 2015 Clin. Chem. pmid:25931455
Tsuchiya H et al. Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice. 2015 Gastroenterology pmid:25701738
Bodewes FA et al. Cholic acid induces a Cftr dependent biliary secretion and liver growth response in mice. 2015 PLoS ONE pmid:25680200
Jiang W et al. Multiscale approach to investigate self-assembly of telodendrimer based nanocarriers for anticancer drug delivery. 2015 Langmuir pmid:25532019
Shih DM et al. PON3 knockout mice are susceptible to obesity, gallstone formation, and atherosclerosis. 2015 FASEB J. pmid:25477283
Gu S et al. A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine. 2015 Mol Biosyst pmid:25411028
Kaur A et al. Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1. 2015 Diabetes pmid:25338812
Shi C et al. A drug-specific nanocarrier design for efficient anticancer therapy. 2015 Nat Commun pmid:26158623
Desai MS et al. Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis. 2015 Liver Int. pmid:24330504
Miura M et al. The Effect of 5-Aminolevulinic Acid on Cytochrome P450-Mediated Prodrug Activation. 2015 PLoS ONE pmid:26181717
Janout V et al. Taming Amphotericin B. 2015 Bioconjug. Chem. pmid:26340430
Wang YD et al. Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3. 2015 Mol. Endocrinol. pmid:25496033
Amjad MW et al. In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas. 2015 Mol. Pharm. pmid:26567518
Nachajski MJ et al. Usefulness of Rosen's postulate for studying the relationship between the structure of cholic acid oxyethylation products and the process of solubilization of lipophilic therapeutic agents (BCS class II and IV) in aqueous solutions in equilibrium. 2014 Jul-Aug Acta Pol Pharm pmid:25272890
Kołodziejczyk MK et al. Surface activity of novel surface active compounds, products of catalytic oxyethylation of cholic acid and their micellar adducts with selected lipophilic therapeutic agents. 2014 Jan-Feb Acta Pol Pharm pmid:24779200
Zhao C et al. An in vitro metabolic system of gut flora and the metabolism of ginsenoside Rg3 and cholic acid. 2014 Eur J Drug Metab Pharmacokinet pmid:23749587
Manley S et al. Suppression of autophagic flux by bile acids in hepatocytes. 2014 Toxicol. Sci. pmid:24189133
Shiraishi T and Nielsen PE Cellular delivery of peptide nucleic acids (PNAs). 2014 Methods Mol. Biol. pmid:24297361
Poša M Heuman indices of hydrophobicity of bile acids and their comparison with a newly developed and conventional molecular descriptors. 2014 Biochimie pmid:24076126
Öner Ö et al. Mechanisms of cholesterol-lowering effects of lactobacilli and bifidobacteria strains as potential probiotics with their bsh gene analysis. 2014 J. Mol. Microbiol. Biotechnol. pmid:24158048
Kosters A et al. Impaired bile acid handling and aggravated liver injury in mice expressing a hepatocyte-specific RXRα variant lacking the DNA-binding domain. 2014 J. Hepatol. pmid:24120911
Luo L et al. Evaluation of serum bile acid profiles as biomarkers of liver injury in rodents. 2014 Toxicol. Sci. pmid:24085190
Jasiewicz B et al. Synthesis and haemolytic activity of novel salts made of nicotine alkaloids and bile acids. 2014 Bioorg. Med. Chem. Lett. pmid:24461290
Hrycay E et al. Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep (-/-) mice. 2014 Mol. Cell. Biochem. pmid:24399466
Harm S et al. Pore size--a key property for selective toxin removal in blood purification. 2014 Int J Artif Organs pmid:25262632
Vařeková RS et al. MotiveValidator: interactive web-based validation of ligand and residue structure in biomolecular complexes. 2014 Nucleic Acids Res. pmid:24848013
Vivian D et al. Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging. 2014 J Pharm Sci pmid:25196788
Xu GQ et al. Association of caveolin-3 and cholecystokinin A receptor with cholesterol gallstone disease in mice. 2014 World J. Gastroenterol. pmid:25071346
Shao Y et al. Block and random copolymers bearing cholic acid and oligo(ethylene glycol) pendant groups: aggregation, thermosensitivity, and drug loading. 2014 Biomacromolecules pmid:24725005
Baptissart M et al. Bile acids alter male fertility through G-protein-coupled bile acid receptor 1 signaling pathways in mice. 2014 Hepatology pmid:24798773
Sun X et al. Metabonomics evaluation of urine from rats administered with phorate under long-term and low-level exposure by ultra-performance liquid chromatography-mass spectrometry. 2014 J Appl Toxicol pmid:23280859
Penno CA et al. 11β-Hydroxysteroid dehydrogenase-1 is involved in bile acid homeostasis by modulating fatty acid transport protein-5 in the liver of mice. 2014 Mol Metab pmid:25061560
Liu J et al. Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures. 2014 Toxicol. Sci. pmid:25055961
Cheng X et al. Decreased bile-acid synthesis in livers of hepatocyte-conditional NADPH-cytochrome P450 reductase-null mice results in increased bile acids in serum. 2014 J. Pharmacol. Exp. Ther. pmid:25034404